CNPV II: Secondary Indications Feature In Second Batch Of US FDA Voucher Winners

 
• By Ramsey Baghdadi
  
Will rapid reviews of secondary indications slide more easily into FDA’s workflow? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards